Skip to main content
ALK-Abelló logo

ALK-Abelló — Investor Relations & Filings

Ticker · ALK ISIN · DK0061802139 LEI · 529900SGCREUZCZ7P020 CO Manufacturing
Open in API
Filings indexed 1,210 across all filing types
Latest filing 2008-04-24 Regulatory Filings
Country DK Denmark
Listing CO ALK

About ALK-Abelló

https://www.alk.net

ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2008
Regulatory Filings
2008-04-24 English
Regulatory Filings 2008
Regulatory Filings
2008-04-24 Danish
Regulatory Filings 2008
Regulatory Filings
2008-04-02 Danish
AGM Information 2008
AGM Information Classification · 98% confidence The document is a formal notice convening an 'Annual General Meeting in ALK-Abelló A/S on April 24, 2008'. The text details the agenda, which includes proposals for the adoption of the annual report, dividend distribution, authority to buy treasury shares, election of directors, and approval of guidelines for incentive pay. The document explicitly mentions that the complete proposals and the audited annual report will be available for inspection and download, and that the guidelines for incentive pay will be considered and approved at the AGM. This structure—a formal invitation and agenda for the shareholder meeting—is characteristic of an AGM notice. While it mentions the Annual Report and Remuneration guidelines (DEF 14A content), the primary purpose of this specific document is to call the meeting and present the items for shareholder vote. Therefore, the most appropriate classification is AGM-R (AGM Information).
2008-04-02 English
Regulatory Filings 2008
Regulatory Filings
2008-03-06 Danish
Director's Dealing 2008
Director's Dealing Classification · 100% confidence The document explicitly reports on 'transactions with ALK-Abelló A/S B shares by managerial staff and their related parties' pursuant to securities trading regulations. It details a 'Purchase' transaction by a 'Member of the Board of Directors' (Lars Simonsen). This directly matches the definition of Director's Dealing (insider trades by executives/directors). The filing type code for this is DIRS.
2008-03-06 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.